Eli Lilly and Company, Taltz, Ixekizumab, Zepbound, Tirzepatide, TOGETHER-PsO, Phase 3b Clinical Trial, Psoriasis, Obesity, Immunometabolic Health, Biomarker Analysis, Neutrophils

Indianapolis, Indiana, USA, October 9, 2026 Eli Lilly and Company has announced new exploratory findings from its Phase 3b...